Medications such as metformin, semaglutide, liraglutide , exenatide and tirzepatide in our patient base are clinically not usually showing lean loss outside of correction of hyperinsulinism- induced excess lean weight-related imbalances
Long-term Sustainability Concerns The outstanding question is maintaining the weight loss
First-time prescribing of both ADM (-23%) and AOM (-9.4%) semaglutide decreased throughout the quarter
Chinas health messaging has long framed obesity as a chronic disease, which has educated the population on the need to take a sustained approach to weight management, she says
The Chinese government's 14th Five-Year Plan for healthcare specifically identifies diabetes management as a chronic disease prevention priority, with investment in guideline-based pharmacotherapy programs that are driving adoption of evidence-based GLP-1 therapy in public healthcare settings Middle East & Africa and Latin America GLP-1 Receptor Agonist Market Insights The Middle East represents a commercially interesting GLP-1 market because the Gulf states combine high rates of type 2 diabetes and obesity the UAE's adult obesity rate exceeds 37%, among the world's highest with high-income consumer populations and expanding private health insurance coverage
With the right plan, you can balance your healthcare expenses, stay on track with weight loss, and protect your health